Delivery of mesenchymal stem cells-derived extracellular vesicles with enriched miR-185 inhibits progression of OPMD

References

• Global Burden of Disease Cancer Collaboration, Fitzmaurice C, Allen C, et al. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the global burden of disease study. JAMA Oncol. 2017;3:524–548.
   PubMed Web of Science ®Google Scholar
• Vigneswaran N, Williams MD. Epidemiologic trends in head and neck cancer and aids in diagnosis. Oral Maxillofac Surg Clin North Am. 2014;26:123–141.
   PubMed Web of Science ®Google Scholar
• Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646–674.
   PubMed Web of Science ®Google Scholar
• Raposo TP, Beirão BC, Pang LY, et al. Inflammation and cancer: till death tears them apart. Vet J. 2015;205:161–174.
   PubMed Web of Science ®Google Scholar
• Multhoff G, Radons J. Radiation, inflammation, and immune responses in cancer. Front Oncol. 2012;2:58.
   PubMedGoogle Scholar
• Zhao Y, Yao J, Wu XP, et al. Wogonin suppresses human alveolar adenocarcinoma cell A549 migration in inflammatory microenvironment by modulating the IL-6/STAT3 signaling pathway. Mol Carcinog. 2015;54(Suppl. 1):E81–E93.
   PubMed Web of Science ®Google Scholar
• Jung IH, Choi JH, Chung YY, et al. Predominant activation of JAK/STAT3 pathway by interleukin-6 is implicated in hepatocarcinogenesis. Neoplasia. 2015;17:586–597.
   PubMed Web of Science ®Google Scholar
• Gasche JA, Hoffmann J, Boland CR, et al. Interleukin-6 promotes tumorigenesis by altering DNA methylation in oral cancer cells. Int J Cancer. 2011;129:1053–1063.
   PubMed Web of Science ®Google Scholar
• Lewis AM, Varghese S, Xu H, et al. Interleukin-1 and cancer progression: the emerging role of interleukin-1 receptor antagonist as a novel therapeutic agent in cancer treatment. J Transl Med. 2006;4:48.
   PubMed Web of Science ®Google Scholar
• Lee CH, Chang JS, Syu SH, et al. IL-1β promotes malignant transformation and tumor aggressiveness in oral cancer. J Cell Physiol. 2015;230:875–884.
   PubMed Web of Science ®Google Scholar
• Josse C, Bours V. MicroRNAs and inflammation in colorectal cancer. Adv Exp Med Biol. 2016;937:53–69.
   PubMed Web of Science ®Google Scholar
• Niu J, Shi Y, Tan G, et al. DNA damage induces NF-κB-dependent microRNA-21 up-regulation and promotes breast cancer cell invasion. J Biol Chem. 2012;287:21783–21795.
   PubMed Web of Science ®Google Scholar
• Jin K, Li T, Sánchez-Duffhues G, et al. Involvement of inflammation and its related microRNAs in hepatocellular carcinoma. Oncotarget. 2017;8:22145–22165.
   PubMedGoogle Scholar
• Sun CC, Zhang L, Li G, et al. The lncRNA PDIA3P interacts with miR-185-5p to modulate oral squamous cell carcinoma progression by targeting cyclin D2. Mol Ther Nucleic Acids. 2017;9:100–110.
   PubMedGoogle Scholar
• Raposo G, Stoorvogel W. Extracellular vesicles: exosomes, microvesicles, and friends. J Cell Biol. 2013;200:373–383.
   PubMed Web of Science ®Google Scholar
• Théry C. Exosomes: secreted vesicles and intercellular communications. F1000 Biol Rep. 2011;3:15.
   PubMedGoogle Scholar
• Lou G, Song X, Yang F, et al. Exosomes derived from miR-122-modified adipose tissue-derived MSCs increase chemosensitivity of hepatocellular carcinoma. J Hematol Oncol. 2015;8:122.
   PubMed Web of Science ®Google Scholar
• Pakravan K, Babashah S, Sadeghizadeh M, et al. MicroRNA-100 shuttled by mesenchymal stem cell-derived exosomes suppresses in vitro angiogenesis through modulating the mTOR/HIF-1α/VEGF signaling axis in breast cancer cells. Cell Oncol. 2017;40:457–470.
   PubMed Web of Science ®Google Scholar
• Müller S. Oral epithelial dysplasia, atypical verrucous lesions and oral potentially malignant disorders: focus on histopathology. Oral Surg Oral Med Oral Pathol Oral Radiol. 2018;125:591–602.
   PubMed Web of Science ®Google Scholar
• EL Andaloussi S, Mäger I, Breakefield XO, et al. Extracellular vesicles: biology and emerging therapeutic opportunities. Nat Rev Drug Discov. 2013;12:347–357.
   PubMed Web of Science ®Google Scholar
• Barile L, Vassalli G. Exosomes: therapy delivery tools and biomarkers of diseases. Pharmacol Ther. 2017;174:63–78.
   PubMed Web of Science ®Google Scholar
• Suchorska WM, Lach MS. The role of exosomes in tumor progression and metastasis. Oncol Rep. 2016;35:1237–1244.
   PubMed Web of Science ®Google Scholar
• Zhang X, Tu H, Yang Y, et al. Mesenchymal stem cell-derived extracellular vesicles: roles in tumor growth, progression, and drug resistance. Stem Cells Int. 2017;2017:1758139.
   PubMed Web of Science ®Google Scholar
• Squillaro T, Peluso G, Galderisi U. Clinical trials with mesenchymal stem cells: an update. Cell Transplant. 2016;25:829–848.
   PubMed Web of Science ®Google Scholar
• Yu B, Zhang X, Li X. Exosomes derived from mesenchymal stem cells. Int J Mol Sci. 2014;15:4142–4157.
   PubMed Web of Science ®Google Scholar
• Camussi G, Deregibus MC, Cantaluppi V. Role of stem-cell-derived microvesicles in the paracrine action of stem cells. Biochem Soc Trans. 2013;41:283–287.
   PubMed Web of Science ®Google Scholar
• Li S, Ma Y, Hou X, et al. MiR-185 acts as a tumor suppressor by targeting AKT1 in non-small cell lung cancer cells. Int J Clin Exp Pathol. 2015;8:11854–11862.
   PubMed Web of Science ®Google Scholar
• Liu C, Li G, Ren S, et al. miR-185-3p regulates the invasion and metastasis of nasopharyngeal carcinoma by targeting WNT2B in vitro. Oncol Lett. 2017;13:2631–2636.
   PubMed Web of Science ®Google Scholar
• Zhao P, Wang S, Zhou Y, et al. MicroRNA-185 regulates spinal cord injuries induced by thoracolumbar spine compression fractures by targeting transforming growth factor-β1. Exp Ther Med. 2017;13:1127–1132.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Liu X, Feng B, et al. STIM1, a direct target of microRNA-185, promotes tumor metastasis and is associated with poor prognosis in colorectal cancer. Oncogene. 2015;34:4808–4820.
   PubMed Web of Science ®Google Scholar
• Markopoulos GS, Roupakia E, Tokamani M, et al. Roles of NF-κB signaling in the regulation of miRNAs impacting on inflammation in cancer. Biomedicines. 2018;6:40.
   PubMed Web of Science ®Google Scholar
• Himaya SW, Ryu B, Qian ZJ, et al. Paeonol from Hippocampus kuda Bleeler suppressed the neuro-inflammatory responses in vitro via NF-κB and MAPK signaling pathways. Toxicol In Vitro. 2012;26:878–887.
   PubMed Web of Science ®Google Scholar
• Wang C, Zeng L, Zhang T, et al. Tenuigenin prevents IL-1β-induced inflammation in human osteoarthritis chondrocytes by suppressing PI3K/AKT/NF-κB signaling pathway. Inflammation. 2016;39:807–812.
   PubMed Web of Science ®Google Scholar
• Zhou J, Miao H, Li X, et al. Curcumin inhibits placental inflammation to ameliorate LPS-induced adverse pregnancy outcomes in mice via upregulation of phosphorylated Akt. Inflamm Res. 2017;66:177–185.
   PubMed Web of Science ®Google Scholar
• Qadir XV, Han C, Lu D, et al. miR-185 inhibits hepatocellular carcinoma growth by targeting the DNMT1/PTEN/Akt pathway. Am J Pathol. 2014;184:2355–2364.
   PubMed Web of Science ®Google Scholar
• Huang H, Song Y, Wu Y, et al. Erbin loss promotes cancer cell proliferation through feedback activation of Akt-Skp2-p27 signaling. Biochem Biophys Res Commun. 2015;463:370–376.
   PubMed Web of Science ®Google Scholar
• Zhang C, Lan T, Hou J, et al. NOX4 promotes non-small cell lung cancer cell proliferation and metastasis through positive feedback regulation of PI3K/Akt signaling. Oncotarget. 2014;5:4392–4405.
   PubMedGoogle Scholar
• Martins F, de Sousa SC, Dos Santos E, et al. PI3K-AKT-mTOR pathway proteins are differently expressed in oral carcinogenesis. J Oral Pathol Med. 2016;45:746–752.
   PubMed Web of Science ®Google Scholar
• Cardone MH, Roy N, Stennicke HR, et al. Regulation of cell death protease caspase-9 by phosphorylation. Science. 1998;282:1318–1321.
   PubMed Web of Science ®Google Scholar
• Nakagawa Y, Takahashi A, Kajihara A, et al. Depression of p53-independent Akt survival signals in human oral cancer cells bearing mutated p53 gene after exposure to high-LET radiation. Biochem Biophys Res Commun. 2012;423:654–660.
   PubMed Web of Science ®Google Scholar
• Chang CH, Lee CY, Lu CC, et al. Resveratrol-induced autophagy and apoptosis in cisplatin-resistant human oral cancer CAR cells: a key role of AMPK and Akt/mTOR signaling. Int J Oncol. 2017;50:873–882.
   PubMed Web of Science ®Google Scholar